Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 01/07 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| 27/05 | Hologic and Biotheranostics Present New Data on Breast Cancer Index Test At Asco 2026 | CI |
| Market Cap | 16.97B 14.85B 13.69B 12.68B 24.08B 1,610B 24.47B 164B 63.81B 795B 63.71B 62.33B 2,747B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 15.22B 14.02B 13B 24.68B 1,650B 25.07B 168B 65.4B 815B 65.29B 63.87B 2,815B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.40% | ||
| Current year | +2.04% |
| Current year | 74.49 | 76.07 | |
| 1 year | 63.19 | 76.07 | |
| 3 years | 51.9 | 84.67 | |
| 5 years | 51.9 | 87.88 | |
| 10 years | 26.49 | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/04 | Issuer sale | Director | 65,866 | 0.0295% | ||
| 07/04 | Issuer sale | Chief Executive Officer | 4,928,217 | 2.2075% | ||
| 07/04 | Issuer sale | Director | 56,632 | 0.0254% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.48% | -.--% | +18.08% | -1.94% | 16.97B | ||
| -0.19% | +3.04% | +23.39% | +0.56% | 192B | ||
| -1.28% | +7.45% | -20.09% | +28.98% | 151B | ||
| +0.29% | +1.95% | -2.73% | -16.69% | 137B | ||
| +1.57% | +6.14% | -56.37% | -13.37% | 67.33B | ||
| -0.38% | +4.82% | +23.64% | +5.05% | 54.6B | ||
| -2.50% | +0.15% | -26.50% | -30.92% | 44.94B | ||
| -1.05% | -0.03% | +8.13% | +41.94% | 36.81B | ||
| +0.41% | -1.27% | +9.97% | +12.09% | 37.04B | ||
| +0.62% | +12.76% | -14.30% | +1.83% | 31.7B | ||
| Average | +0.07% | +4.00% | -3.68% | +2.75% | 77.02B | |
| Weighted average by Cap. | +0.28% | +4.01% | -2.72% | +2.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.53B 3.25B 3.01B 5.72B 383B 5.81B 38.98B 15.16B 189B 15.13B 14.8B 652B | 4.1B 3.59B 3.31B 3.07B 5.82B 389B 5.91B 39.65B 15.42B 192B 15.39B 15.06B 664B |
| Net income | 790M 691M 637M 590M 1.12B 74.93B 1.14B 7.63B 2.97B 36.98B 2.96B 2.9B 128B | 566M 495M 456M 423M 803M 53.69B 816M 5.47B 2.13B 26.5B 2.12B 2.08B 91.59B |
| Net Debt | 321M 281M 259M 240M 456M 30.49B 463M 3.11B 1.21B 15.05B 1.21B 1.18B 52.02B | 421M 368M 339M 315M 597M 39.95B 607M 4.07B 1.58B 19.71B 1.58B 1.55B 68.14B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions


















